author-photo

Emmanuel Fleck

15

Papers

25

Citations

Citation Trend

Filter By

Papers (10) Sort By

Journal Conference Others

Low‐dose tyrosine kinase inhibitors before treatment discontinuation do not impair treatment‐free remission in chronic myeloid leukemia patients: Results of a retrospective study

2020 Cancer
Show All
- Source
- Cite
- Save
Citations (5)
Oral CHOP‐like chemotherapy in 60–80 years‐old patients with diffuse large B‐cell lymphoma

2019 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (0)
Oral CHOP-like Chemotherapy in Elderly Patients with High-Grade Non Hodgkin B Cell Lymphoma

2018 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Carfilzomib Weekly 20/56mg/m², Lenalidomide and Dexamethasone for Early Relapsed Refractory Multiple Myeloma

2018 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Phase 1/2 Study of Orociep All Oral Regimen with Idarubicin, Cyclophosphamide, Etoposide, Prednisolone in Combination to Intravenous Rituximab in Elderly Patients with Disseminated High Grade Non Hodgkin Lymphoma. Final Analysis

2017 Blood
Show All
- Source
- Cite
- Save
Citations (0)
THE 5-YEAR FOLLOW-UP RESULTS OF THE C5R PROTOCOL WITH RITUXIMAB AND INTRATHECAL LIPOSOMAL CYTARABINE FOR PRIMARY CNS LYMPHOMA: A PROSPECTIVE PHASE 2 STUDY OF THE LYSA

2017 Hematological Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Impact of BMI and Gender on Outcomes in DLBCL Patients Treated with R-CHOP: A Pooled Study from the LYSA

2014
Show All
- Source
- Cite
- Save
Citations (10)
Incidence des événements indésirables après réintroduction sur le marché d’une immunoglobuline intraveineuse : analyse intermédiaire de l’étude GAMMATRACK

2014 Revue de Médecine Interne
Show All
- Source
- Cite
- Save
Citations (0)
A Multicentric Prospective Phase 2 Study of Intravenous Rituximab and Intrathecal Liposomal Cytarabine in Combination with C5R Protocol Followed by Brain Radiotherapy for Immunocompetent Patients with Primary CNS Lymphoma: A Lymphoma Study Association (LYSA) Trial

2012 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Phase I/II Study of Escalating Doses of Idarubicin Orally Given with Oral Cyclophosphamide, Etoposide, Prednisolone and Intravenous Rituximab in Elderly Patients with Disseminated High Grade Non Hodgkin Lymphoma.

2009 Blood
Show All
- Source
- Cite
- Save
Citations (0)